In the present study, we also observed that a CD4+ T-cell count <300 cells/μL was an independent risk factor for progression to severe COVID-19, suggesting that patients with milder COVID-19 develop CD4+ T-cell count depletion before significant disease progression, which was similar to the study conducted in Shanghai [17]. The gene discussed is CD4; the disease is COVID-19.